Calidi Biotherapeutics (CLDI) Total Non-Current Liabilities (2021 - 2026)
Calidi Biotherapeutics (CLDI) reported Total Non-Current Liabilities of $4.01 million for Q2 2026, down 44.2% from $7.18 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Calidi Biotherapeutics posted Total Non-Current Liabilities of $4.99 million, down 58.7% from FY2024.
- Total Non-Current Liabilities has a four-year compound annual growth rate of -25.3% (FY2021 to FY2025).
- By year, Total Non-Current Liabilities came in at $12.1 million in FY2024 (-31.4%), $17.63 million in FY2023, $1.07 million in FY2022 (-93.3%) and $16.04 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q1 2023.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2024 (growth of 285.3%); the low point was Q4 2022 (a decline of 93.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Calidi Biotherapeutics | 991,199.98 | -25.74 Mn | - | 4.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.01 Mn |
| Mar 31, 2026 | 4.59 Mn |
| Dec 31, 2025 | 4.99 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 7.18 Mn |
| Mar 31, 2025 | 7.68 Mn |
| Dec 31, 2024 | 12.10 Mn |
| Sep 30, 2024 | 16.29 Mn |
| Jun 30, 2024 | 17.66 Mn |
| Mar 31, 2024 | 21.33 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 16.22 Mn |
| Jun 30, 2023 | 4.58 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 9.03 Mn |
| Jun 30, 2022 | 9.71 Mn |
| Mar 31, 2022 | 14.07 Mn |
| Dec 31, 2021 | 16.04 Mn |
| Sep 30, 2021 | 230.09 Mn |
API Access
Calidi Biotherapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();